Pharmaceuticals
New Treasury rules threaten Allergan-Pfizer merger
05 Apr 2016
The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm
NPPA brings down prices of 103 drug formulations
02 Apr 2016
Doctors who got more money from pharma companies prescribed more brand-name drugs: study
19 Mar 2016
Doctors who accept payments from pharmaceutical firms and medical-device makers in the US are twice as likely to prescribe more expensive drugs, reveals a recent study
